nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—ABCB1—adrenal gland cancer	0.792	1	CbGaD
Amantadine—DDC—Nicotine Activity on Dopaminergic Neurons—PRKACA—adrenal gland cancer	0.00456	0.0219	CbGpPWpGaD
Amantadine—GRIN2C—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.0042	0.0202	CbGpPWpGaD
Amantadine—GRIN2D—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.0039	0.0187	CbGpPWpGaD
Amantadine—GRIN2C—Post NMDA receptor activation events—PRKACA—adrenal gland cancer	0.00374	0.018	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.00372	0.0178	CbGpPWpGaD
Amantadine—GRIN2D—Post NMDA receptor activation events—PRKACA—adrenal gland cancer	0.00348	0.0167	CbGpPWpGaD
Amantadine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—PRKACA—adrenal gland cancer	0.00344	0.0165	CbGpPWpGaD
Amantadine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00337	0.0162	CbGpPWpGaD
Amantadine—GRIN2A—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.00321	0.0154	CbGpPWpGaD
Amantadine—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—PRKACA—adrenal gland cancer	0.0032	0.0154	CbGpPWpGaD
Amantadine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00313	0.015	CbGpPWpGaD
Amantadine—SLC22A2—Abacavir transport and metabolism—ABCB1—adrenal gland cancer	0.00293	0.0141	CbGpPWpGaD
Amantadine—GRIN2A—Post NMDA receptor activation events—PRKACA—adrenal gland cancer	0.00286	0.0137	CbGpPWpGaD
Amantadine—GRIN1—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.0028	0.0134	CbGpPWpGaD
Amantadine—SLC22A1—Abacavir transport and metabolism—ABCB1—adrenal gland cancer	0.00273	0.0131	CbGpPWpGaD
Amantadine—GRIN2B—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.00273	0.0131	CbGpPWpGaD
Amantadine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—PRKACA—adrenal gland cancer	0.00263	0.0126	CbGpPWpGaD
Amantadine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00257	0.0123	CbGpPWpGaD
Amantadine—GRIN2C—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00253	0.0121	CbGpPWpGaD
Amantadine—GRIN1—Post NMDA receptor activation events—PRKACA—adrenal gland cancer	0.00249	0.012	CbGpPWpGaD
Amantadine—GRIN2C—CREB phosphorylation through the activation of Ras—BRAF—adrenal gland cancer	0.00245	0.0118	CbGpPWpGaD
Amantadine—GRIN2B—Post NMDA receptor activation events—PRKACA—adrenal gland cancer	0.00243	0.0117	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00235	0.0113	CbGpPWpGaD
Amantadine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—PRKACA—adrenal gland cancer	0.00229	0.011	CbGpPWpGaD
Amantadine—GRIN2D—CREB phosphorylation through the activation of Ras—BRAF—adrenal gland cancer	0.00228	0.0109	CbGpPWpGaD
Amantadine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00224	0.0108	CbGpPWpGaD
Amantadine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—PRKACA—adrenal gland cancer	0.00224	0.0107	CbGpPWpGaD
Amantadine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ5—adrenal gland cancer	0.00218	0.0105	CbGpPWpGaD
Amantadine—GRIN2C—Post NMDA receptor activation events—BRAF—adrenal gland cancer	0.00202	0.00967	CbGpPWpGaD
Amantadine—GRIN1—EPHB-mediated forward signaling—CDC42—adrenal gland cancer	0.00195	0.00934	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—KCNJ5—adrenal gland cancer	0.00194	0.0093	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00193	0.00927	CbGpPWpGaD
Amantadine—GRIN2B—EPHB-mediated forward signaling—CDC42—adrenal gland cancer	0.0019	0.0091	CbGpPWpGaD
Amantadine—GRIN2D—Post NMDA receptor activation events—BRAF—adrenal gland cancer	0.00187	0.00899	CbGpPWpGaD
Amantadine—GRIN2A—CREB phosphorylation through the activation of Ras—BRAF—adrenal gland cancer	0.00187	0.00897	CbGpPWpGaD
Amantadine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.00186	0.00891	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—KCNJ5—adrenal gland cancer	0.0018	0.00865	CbGpPWpGaD
Amantadine—DRD2—Nicotine Activity on Dopaminergic Neurons—PRKACA—adrenal gland cancer	0.0018	0.00863	CbGpPWpGaD
Amantadine—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.00173	0.00828	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00168	0.00809	CbGpPWpGaD
Amantadine—MAOB—Alpha-synuclein signaling—BAD—adrenal gland cancer	0.00166	0.00799	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.00164	0.00788	CbGpPWpGaD
Amantadine—GRIN1—CREB phosphorylation through the activation of Ras—BRAF—adrenal gland cancer	0.00163	0.00783	CbGpPWpGaD
Amantadine—GRIN2B—CREB phosphorylation through the activation of Ras—BRAF—adrenal gland cancer	0.00159	0.00763	CbGpPWpGaD
Amantadine—GRIN2A—Post NMDA receptor activation events—BRAF—adrenal gland cancer	0.00154	0.00739	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—KCNJ5—adrenal gland cancer	0.00148	0.0071	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.00147	0.00704	CbGpPWpGaD
Amantadine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.00142	0.0068	CbGpPWpGaD
Amantadine—GRIN1—Post NMDA receptor activation events—BRAF—adrenal gland cancer	0.00134	0.00644	CbGpPWpGaD
Amantadine—GRIN2B—Post NMDA receptor activation events—BRAF—adrenal gland cancer	0.00131	0.00628	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—KCNJ5—adrenal gland cancer	0.00129	0.0062	CbGpPWpGaD
Amantadine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.00129	0.00619	CbGpPWpGaD
Amantadine—DRD2—Hypothetical Network for Drug Addiction—PRKACA—adrenal gland cancer	0.00128	0.00616	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—KCNJ5—adrenal gland cancer	0.00126	0.00604	CbGpPWpGaD
Amantadine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.00124	0.00593	CbGpPWpGaD
Amantadine—GRIN2C—Alzheimers Disease—BAD—adrenal gland cancer	0.00121	0.00579	CbGpPWpGaD
Amantadine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—BRAF—adrenal gland cancer	0.00121	0.00578	CbGpPWpGaD
Amantadine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.0012	0.00576	CbGpPWpGaD
Amantadine—GRIN2D—Alzheimers Disease—BAD—adrenal gland cancer	0.00112	0.00538	CbGpPWpGaD
Amantadine—GRIN1—EPH-Ephrin signaling—CDC42—adrenal gland cancer	0.001	0.00481	CbGpPWpGaD
Amantadine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.000985	0.00473	CbGpPWpGaD
Amantadine—GRIN2B—EPH-Ephrin signaling—CDC42—adrenal gland cancer	0.000977	0.00469	CbGpPWpGaD
Amantadine—GRIN2C—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00097	0.00465	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—BAD—adrenal gland cancer	0.000921	0.00442	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.000917	0.0044	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.000901	0.00433	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.000876	0.0042	CbGpPWpGaD
Amantadine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.000859	0.00412	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.00085	0.00408	CbGpPWpGaD
Amantadine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACA—adrenal gland cancer	0.000837	0.00402	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—CDC42—adrenal gland cancer	0.000835	0.00401	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—KCNJ5—adrenal gland cancer	0.000816	0.00392	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—BAD—adrenal gland cancer	0.000804	0.00386	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.000788	0.00378	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—BAD—adrenal gland cancer	0.000783	0.00376	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—PRKACA—adrenal gland cancer	0.000743	0.00357	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00074	0.00355	CbGpPWpGaD
Amantadine—MAOB—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000733	0.00352	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—NR5A1—adrenal gland cancer	0.000714	0.00343	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—CDC42—adrenal gland cancer	0.000712	0.00342	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—NR5A1—adrenal gland cancer	0.000696	0.00334	CbGpPWpGaD
Amantadine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.000695	0.00334	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—CDC42—adrenal gland cancer	0.000694	0.00333	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—PRKACA—adrenal gland cancer	0.000691	0.00332	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—KCNJ5—adrenal gland cancer	0.000671	0.00322	CbGpPWpGaD
Amantadine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.000646	0.0031	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.000646	0.0031	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.000629	0.00302	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—KCNJ5—adrenal gland cancer	0.000625	0.003	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—PRKACA—adrenal gland cancer	0.000567	0.00272	CbGpPWpGaD
Amantadine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	0.000565	0.00271	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00054	0.00259	CbGpPWpGaD
Amantadine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.000531	0.00255	CbGpPWpGaD
Amantadine—GRIN2C—Alzheimers Disease—TP53—adrenal gland cancer	0.000528	0.00253	CbGpPWpGaD
Amantadine—GRIN2C—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000522	0.00251	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—RB1—adrenal gland cancer	0.000521	0.0025	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—BAD—adrenal gland cancer	0.000497	0.00239	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—PRKACA—adrenal gland cancer	0.000495	0.00237	CbGpPWpGaD
Amantadine—GRIN2D—Alzheimers Disease—TP53—adrenal gland cancer	0.000491	0.00236	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000486	0.00233	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—BAD—adrenal gland cancer	0.000485	0.00233	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—PRKACA—adrenal gland cancer	0.000482	0.00231	CbGpPWpGaD
Amantadine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.000463	0.00222	CbGpPWpGaD
Amantadine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.000451	0.00217	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—MED12—adrenal gland cancer	0.000429	0.00206	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.000429	0.00206	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—MED12—adrenal gland cancer	0.000419	0.00201	CbGpPWpGaD
Amantadine—DDC—Metabolism—SDHB—adrenal gland cancer	0.000414	0.00199	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.000411	0.00197	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—TP53—adrenal gland cancer	0.000403	0.00194	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—BRAF—adrenal gland cancer	0.0004	0.00192	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000399	0.00191	CbGpPWpGaD
Amantadine—MAOB—Biological oxidations—POMC—adrenal gland cancer	0.000389	0.00187	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000376	0.00181	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—CDC42—adrenal gland cancer	0.000372	0.00179	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—BRAF—adrenal gland cancer	0.000372	0.00179	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—CDC42—adrenal gland cancer	0.000363	0.00174	CbGpPWpGaD
Amantadine—DDC—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000357	0.00171	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—TP53—adrenal gland cancer	0.000352	0.00169	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00035	0.00168	CbGpPWpGaD
Amantadine—MAOB—Metabolism—SDHB—adrenal gland cancer	0.000348	0.00167	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000348	0.00167	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—TP53—adrenal gland cancer	0.000343	0.00165	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000339	0.00163	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.000336	0.00161	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.000335	0.00161	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.000327	0.00157	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000324	0.00155	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.000319	0.00153	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.000313	0.0015	CbGpPWpGaD
Amantadine—GRIN1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.000307	0.00147	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—BRAF—adrenal gland cancer	0.000306	0.00147	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—EGFR—adrenal gland cancer	0.000304	0.00146	CbGpPWpGaD
Amantadine—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000303	0.00145	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000288	0.00138	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—BRAF—adrenal gland cancer	0.000267	0.00128	CbGpPWpGaD
Amantadine—DDC—Metabolism—SDHD—adrenal gland cancer	0.000267	0.00128	CbGpPWpGaD
Amantadine—DDC—Metabolism—RRM1—adrenal gland cancer	0.000267	0.00128	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—CDC42—adrenal gland cancer	0.000266	0.00128	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—BRAF—adrenal gland cancer	0.00026	0.00125	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—CDC42—adrenal gland cancer	0.000259	0.00124	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—PRKACA—adrenal gland cancer	0.000257	0.00123	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TP53—adrenal gland cancer	0.000255	0.00122	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000246	0.00118	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—PRKACA—adrenal gland cancer	0.00024	0.00115	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000232	0.00112	CbGpPWpGaD
Amantadine—MAOB—Metabolism—SDHD—adrenal gland cancer	0.000224	0.00108	CbGpPWpGaD
Amantadine—MAOB—Metabolism—RRM1—adrenal gland cancer	0.000224	0.00108	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00022	0.00105	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000216	0.00104	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000211	0.00101	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.000211	0.00101	CbGpPWpGaD
Amantadine—DDC—Metabolism—MED12—adrenal gland cancer	0.000199	0.000954	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—TP53—adrenal gland cancer	0.000194	0.000931	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—SDHB—adrenal gland cancer	0.000185	0.000887	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000181	0.000868	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SDHB—adrenal gland cancer	0.000172	0.000827	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000169	0.000809	CbGpPWpGaD
Amantadine—MAOB—Metabolism—MED12—adrenal gland cancer	0.000167	0.000803	CbGpPWpGaD
Amantadine—DDC—Metabolism—PRKACA—adrenal gland cancer	0.000145	0.000696	CbGpPWpGaD
Amantadine—DRD2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.000142	0.000682	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000139	0.000668	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—BRAF—adrenal gland cancer	0.000139	0.000665	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000138	0.000664	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—EGFR—adrenal gland cancer	0.000135	0.00065	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—EGFR—adrenal gland cancer	0.000132	0.000634	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—BRAF—adrenal gland cancer	0.000129	0.00062	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000129	0.000619	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—GNAS—adrenal gland cancer	0.000128	0.000613	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000126	0.000607	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000125	0.000599	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000124	0.000596	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PRKACA—adrenal gland cancer	0.000122	0.000586	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—CTNNB1—adrenal gland cancer	0.000122	0.000586	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—RRM1—adrenal gland cancer	0.000119	0.000572	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—SDHD—adrenal gland cancer	0.000119	0.000572	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—CTNNB1—adrenal gland cancer	0.000119	0.000571	CbGpPWpGaD
Amantadine—DDC—Metabolism—GNAS—adrenal gland cancer	0.000118	0.000564	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000116	0.000557	CbGpPWpGaD
Amantadine—DDC—Metabolism—ABCB1—adrenal gland cancer	0.000115	0.000554	CbGpPWpGaD
Amantadine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000113	0.000542	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000113	0.000541	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000113	0.000541	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000112	0.000538	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—RRM1—adrenal gland cancer	0.000111	0.000533	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—SDHD—adrenal gland cancer	0.000111	0.000533	CbGpPWpGaD
Amantadine—SLC22A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00011	0.000528	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000109	0.000523	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000104	0.000501	CbGpPWpGaD
Amantadine—SLC22A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000102	0.000492	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SDHB—adrenal gland cancer	0.000101	0.000485	CbGpPWpGaD
Amantadine—MAOB—Metabolism—GNAS—adrenal gland cancer	9.89e-05	0.000475	CbGpPWpGaD
Amantadine—MAOB—Metabolism—ABCB1—adrenal gland cancer	9.71e-05	0.000466	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—EGFR—adrenal gland cancer	9.66e-05	0.000464	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—EGFR—adrenal gland cancer	9.42e-05	0.000452	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—MED12—adrenal gland cancer	8.88e-05	0.000426	CbGpPWpGaD
Amantadine—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	8.6e-05	0.000413	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	8.28e-05	0.000397	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—MED12—adrenal gland cancer	8.27e-05	0.000397	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	8.09e-05	0.000388	CbGpPWpGaD
Amantadine—DDC—Metabolism—POMC—adrenal gland cancer	7.91e-05	0.00038	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	7.64e-05	0.000367	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	7.56e-05	0.000363	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	7.55e-05	0.000363	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	7.47e-05	0.000359	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	7.41e-05	0.000356	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	7.22e-05	0.000347	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	6.86e-05	0.000329	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	6.83e-05	0.000328	CbGpPWpGaD
Amantadine—MAOB—Metabolism—POMC—adrenal gland cancer	6.66e-05	0.00032	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	6.66e-05	0.00032	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	6.56e-05	0.000315	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—SDHD—adrenal gland cancer	6.5e-05	0.000312	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—RRM1—adrenal gland cancer	6.5e-05	0.000312	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PRKACA—adrenal gland cancer	6.48e-05	0.000311	CbGpPWpGaD
Amantadine—DDC—Metabolism—PTGS2—adrenal gland cancer	6.31e-05	0.000303	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	6.26e-05	0.000301	CbGpPWpGaD
Amantadine—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	6.12e-05	0.000294	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PRKACA—adrenal gland cancer	6.04e-05	0.00029	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	5.87e-05	0.000282	CbGpPWpGaD
Amantadine—MAOB—Metabolism—PTGS2—adrenal gland cancer	5.31e-05	0.000255	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—GNAS—adrenal gland cancer	5.25e-05	0.000252	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—ABCB1—adrenal gland cancer	5.15e-05	0.000247	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.93e-05	0.000237	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—GNAS—adrenal gland cancer	4.89e-05	0.000235	CbGpPWpGaD
Amantadine—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	4.86e-05	0.000233	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—MED12—adrenal gland cancer	4.85e-05	0.000233	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—ABCB1—adrenal gland cancer	4.8e-05	0.00023	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	4.78e-05	0.000229	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	4.41e-05	0.000212	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	4.05e-05	0.000195	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	3.91e-05	0.000188	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	3.87e-05	0.000186	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	3.78e-05	0.000181	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	3.54e-05	0.00017	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—POMC—adrenal gland cancer	3.53e-05	0.00017	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—POMC—adrenal gland cancer	3.29e-05	0.000158	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TERT—adrenal gland cancer	3.25e-05	0.000156	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.87e-05	0.000138	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—BAD—adrenal gland cancer	2.83e-05	0.000136	CbGpPWpGaD
Amantadine—SLC22A2—Metabolism—PTGS2—adrenal gland cancer	2.82e-05	0.000135	CbGpPWpGaD
Amantadine—SLC22A1—Metabolism—PTGS2—adrenal gland cancer	2.63e-05	0.000126	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—POMC—adrenal gland cancer	2.61e-05	0.000125	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	2.58e-05	0.000124	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	2.5e-05	0.00012	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—POMC—adrenal gland cancer	1.93e-05	9.27e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	1.86e-05	8.93e-05	CbGpPWpGaD
Amantadine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.54e-05	7.39e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	1.47e-05	7.08e-05	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TP53—adrenal gland cancer	1.24e-05	5.94e-05	CbGpPWpGaD
